NCT03160001View on ClinicalTrials.gov

Niclosamide With Etanercept in Rheumatoid Arthritis

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

August 15, 2017

Primary Completion Date

August 15, 2018

Study Completion Date

December 10, 2018

Conditions
Rheumatoid Arthritis (RA)
Interventions
DRUG

Placebo

Patients with active RA and receive Etanercept for 8 weeks.: Placebo lactose 500mg cap twice daily

DRUG

Niclosamide

Patients with active RA and receive etanercept with niclosamide cap 500mg twice daily orally as adjuvant therapy for 8 weeks

DRUG

Etanercept

Etanercept 50mg weekly

Trial Locations (1)

Unknown

Baghdad teaching Hospital, Baghdad

All Listed Sponsors
lead

Faiq Gorial

OTHER

NCT03160001 - Niclosamide With Etanercept in Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter